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    A 46-year-old female was found to have concurrence of recurrent thymoma and lung 
cancer because of a transient blephaloptosis which appeared 14 years following removal of 
the primary thymoma. Primary thymoma was non-invasive, but recurrent thymoma invaded 
anterior chest wall. One year after the second operation, blephaloptosis recurred and the 
patient was diagnosed as myasthenia, occular type. Recurrence of non-invasive thymoma 
is rare. And that recurrent thymoma occurred simultaneously with lung cancer is not found 
in the literature. Occurrence of extra-thymic malignancy has no relationship with the 
progression of thymoma and may present in multiple organs. Elevation of serum-CEA was 
noted in the present case. Review of the thymomas treated in our department shows that 
serum-CEA may be used as an indicator of recurrence or progression of thymoma.
      Recurrence is frequently seen in invasive thymoma, but rare in totally resected 
non-invasive thymoma. A variety of non-thymic malignancies have been reported in as-
sociation with thymoma. Very little information is available for the concurrence of a 
recurrent non-invasive thymoma with a lung cancer. In this report, the literature was 
reviewed and analyzed to search the causes of recurrence of non-invasive thymoma, and 
the relationship between thymoma and non-thymic malignancy.
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                   CASE REPORT 
      Patient was a 46-year-old female. On a routine examination at age 32, chest x-ray 
showed a right hilar mass shadow. At that time, an encapsulated anterior mediasti nal 
tumor was resected without difficulty through a median sternotomy. The pathologic diag-
nosis was benign (or non-invasive), lymphocytic type of thymoma. There was no com-
plication of parathymic syndrome in her history. -
      Acute onset of left blephaloptosis occurred 14 years after removal of the thymoma. 
Chest x-ray demonstrated a large mass shadow in the right cardiophrenic angle and a 
small mass shadow in the right mid-lung field. Recurrence of the thymoma with pulmon-
ary metastasis was suspected and she was admitted for further examination. The symptom 
of blephaloptosis disappeared without medical treatment on admission. 
      On physical examination, a 2.5X2.0 cm, ill-defined elastic and hard tumor was 
palpated at the medial side of the right hypochondrium. No lymphadenopathy was ob-
served in the neck and the bilateral axillae. CT scan at the level of the xiphoid process 
showed a regular homogenous mass protruding from the anterior lower mediastinum to the 
right thoracic cavity and involving the right anterior chest wall. CT scan at the level of 
the carina demonstrated an irregular mass in the superior segment of the right lower lobe 
with pleural indentation. No enlargement of mediastinal lymph nodes was found. 
     Hematologic evaluation showed no abnormal findings. Gammaglobulin level was 
normal. Carcinoembryonic antigen (CEA, DAINABOT) value was 3.1 ng/ml, and alpha-
protein was 8.9 ng/ml. 
      At , operation, an anterolateral thoracotomy was performed through the 5th intercostal 
space. A greyish ball-shaped tumor was located in the lower anterior mediastinum con-
tiguous to the pericardium, protruding into the right pleural cavity with invasion to the 
anterior lower chest wall. On palpation, there was a lung tumor in the superior segment 
of the right lower lobe with pleural indentation. During the operation, frozen section of 
the lung tumor was diagnosed as lung cancer (adenocarcinoma). Then the left lower 
lobectomy with mediastinal lymphadenectomy was performed. Anterior lower mediastinal 
tumor was resected with the invaded chest wall. The defect of the anterior chest wall 
was replaced with a one-folded Marlex-mesh® (DAVOL). The patient recovered well 
postoperatively without instability of the right chest wall during respiratory movement. 
     One year later, blephaloptosis recurred with double vision and the symptoms re-
sponded to Tensilon. Chest x-ray and CT scan showed no recurrence of the thymoma 
and lung cancer. Analysis of the T-cell subpopulations in the blood was normal. The 
titer of antibody against acetylcholine receptors in the serum was high (27 nmol/L). An 
occular type of myasthenia gravis was diagnosed and adequately controlled by prednisolone 
and Myte] ase (Ambenonium chloride).
                   PATHOLOGY 
     The tumor which occurred at age 32 was located in the right lobe of the thymus, 
weighing 90 gm, measuring 11 x 7 x 7 cm in size. It was encapsulated by fibrous tissue 
which was slightly adherent to the pericardium and mediastinal pleura. However, it was
Fig. 1 <A> Photomicrograph of the primary thymoma showing lymphocytic 
               predominance. (Hematoxylin-eosin, X248) 
       <B> Photomicrograph of the recurrent thymoma showing mixec 
               type. (Hematoxylin-eosin, X248)
easily removed at operation. The cut surfaces were grey, solid with a cyst on the left 
measuring 2.5 x 2.5 x 2.0 cm. Microscopically, the tumor was lobulated by fibrous septa. 
The tumor lobules were composed of sheets of mature lymphocytes and sparse epithelial 
elements (Fig. 1, A). HASSALL's corpuscles were not identified in the tumor tissue. 
Tumor cells were confined to the capsule without infiltration. 
     The recurrent thymoma with the invaded chest wall were resected en block. The 
resected chest wall contained the 5th, 6th, 7th and 8th ribs as well as the intercostal 
muscles which were severed 2cm apart from the invaded margin of the thymoma. Micro-
scopically, the tumor was irregularly lobulated by fibrous septa. The tumor lobules 
consisted of lymphocytes and epithelial cells (Fig. 1, B). The ratios of lymphocyte and 
epithelial cell were different from area to area but both components were usually inter-
mingled. Tumor cells showed a slight degree of cellular pleomorphism and nuclear atypia 
without mitotic figures. Minimal invasion of tumor cells was found into the intercostal 
muscles. 
      The cut surfaces of the lung tumor were grey, measuring 2.5X2.5 cm. Micro-
scopically, the tumor cells extended along the alveolar wall, partially showing a papillary 
pattern with moderate mucin production (Fig. 2). There were no metastases to the me-
diastinal or hilar lymph nodes.
Fig. 2 Bronchiolo-alveolar adenocarcinoma. Tumor cells were growing along 
       the alveolar wall with mucin production. (Hematoxylin-eosin, X248)
                    DISCUSSION 
      Excluding germinal cell tumor, malignant lymphoma, carcinoid tumor, non-specific 
cyst and hyperplasia of thymus, 46 cases of thymoma were diagnosed and treated in our 
department from 1956 to 1983. Recurrence of non-invasive or encapsulated thymoma is 
rare. Among them only one of 30 non-invasive cases recurred after resection of thymoma. 
Based on a review of literature, 20 cases of recurrent non-invasive thymoma were col-
lected.'") All the patients were adults and the ages ranged from 22 to 64 years. The 
distribution of males and females were almost the same. About half of the cases were 
associated with myasthenia gravis. The time of recurrence ranged from 1 year 4 months 
to 19 years postoperatively. Recurrence of non-invasive thymoma usually occurred in two 
ways ; (1) local recurrence in mediastinum or (2) pleural dissemination. In 2 cases,') 
recurrences were seen both in mediastinum and pleura. Distant metastases of non-invasive 
thymomas to the supraclavicular region," axillary nodes,') and cervical lymphnodes6) were 
also found. 
     Most of the intrathoracic metastatic form of thymoma are pleural dissemination. 
Pulmonary parenchymal metastases may occur as well.")") Since our patient had a history 
of thymoma, the mass shadows in the right lung field and mediastinum led to the preoper-
ative diagnosis of recurrent thymoma with pulmonary metastasis. 
     Unusually, thymoma develops as multiple separate nodules in the thymic gland. 12) 
Several ectopic thymomas have also been reported. The sites of local recurrence of the 
non-invasive thymomas in mediastinum varied from those of primary tumors in our case 
and 3 cases found in literature.1)4) It has been shown that thymic tissue exists in high 
frequency in the anterior mediastinum outside the capsule of the thymus.") The facts 
suggest that undetected small thymoma in the thymus during operation or newly developed 
thymoma from the postoperative remnant of thymic gland may be considered as the causes 
of recurrent non-invasive thymoma including the presented case. It has been emphasized 
recently that low recurrence and high survival rates in the well-encapsulated cases and 
those without invasive growth into the surrounding organs are due to extensive excision 
of the tumor with surrounding tissues. OW To treat and prevent local recurrence of 
thymoma, complete removal of thymoma and thymic gland is warranted in both the cases 
associated with myasthenia gravis and those without myasthenia. It is considered that the 
operative procedure is the predisposing factor of pleural dissemination. However, pleural 
dissemination can occur spontaneously without surgical treatment. Preoperative radiothera-
py had been used to prevent pleural dissemination. WEISSBERG et al. reported that none 
of the patients developed pleural metastasis after preoperative radiotherapy.") Preoperative 
radiotherapy may decrease the incidence of pleural metastasis. 
      In five well-documented cases, 1)4)9) histology of primary non-invasive and recurrent 
thymoma were all identical (2 lymphocytic, 3 mixed type). Only one case of mixed type 
recurred as a similar type but with malignant change (mitoses). 9) In the present case, 
the histological types of the primary thymoma and recurrent thymoma were lymphocytic
and mixed type without mitotic figures 
respectively. We have no explanation 
about the difference of the histological 
types between primary and recurrent 
tumor. 
     Since SOUADJIAN16) reported that 
incidence of non-thymic malignancy in-
creases markedly in patients with thymoma, 
a few articles have described concomitant 
thymoma and extra-thymic malignancy. 
With the exception of the cases reported 
by SOUADJIAN, 33 patients were collected 
from literature. The distribution and sites 
of non-thymic malignancy are shown in 
Table 1. It has been suggested by 
LEGOLVA N3> that there is an increased 
occurrence of second primary malignant 
neoplasms in patients with thymomas, 
particularly of the embryologically related 
thyroid gland. Though malignant lesions
   Table 1. Distribution of non-thymic 
            malignancy 
     Site Cases 
 Lung 8 
 Bone marrow 8 
    (Leukemia) (6) 
    (Myeloma) (2) 
 Thyroid gland 5
 Brain 2 
 Breast 2 
 Stomach 2 
 Tongue 1 
 Small intestine 1 
 Rectum 1 
 Colon 1 
 Urinary bladder 1 
 Liver (Lymphoma) 1 
 Inguinal & pulmonary 
 lymphnodes (Lymphoma) 1 
 Arm (Fibrosarcoma) 1 
 (References 2-5, 8, 11, 17-32)
were observed more commonly in lung, bone marrow and thyroid gland, the number of 
cases is too small to conclude that malignancy is more prone to develop in those organs. 
Five of 33 patients developed neoplasms in 2 different sites as follows : (1) lung cancer 
and breast cancer," (2) leukemia (bone marrow) and urinary bladder cancer,") (3) lym-
phoma (small intestine) and lung cancer,"') (4) gastric cancer and lymphoma (lymph 
nodes),") (5) thyroid cancer and rectal cancer.") 
     In the 33 thymomas associated with non-thymic neoplasms, 14 were non-invasive or 
well-encapsulated, 5 were invasive. There are no description about the macroscopic find-
ings in the remaining 14 cases. It seems that progression of thymoma is not related to the 
incidence of non-thymic neoplasms. 
     Including the case presented herein, 9 lung cancers associated with thymoma have 
been reported. The histologic type of the thymoma were 1 epithelial, 1 lymphocytic, 3 
mixed, 1 spindle cell and 3 unknown. The pathologic diagnoses of the lung cancers 
were squamous cell carcinoma 2 , adenocarcinoma 2, mucinous carcinoma 1 and unknown 
4 . Analysis of these data discloses no obvious trend beween histological type of thymoma 
and histological type of lung cancer. The cause of the increased frequency of non-thymic 
malignancy in thymoma is not clear. It is considered that disturbance of immunological 
surveillance, states of immunodeficiency or immunosuppression are associated with an in-
creased incidence of malignancy33 . In our case, gammaglobulin level and T-cell subpopu-
lations were normal. 
     Preoperative value of serum-CEA in the present case was 3.1 ng/ml (normal value :
below 2.5 ng/ml). Postoperative studies of serum-CEA were all less than 1.0 ng/ml. Eleva-
tion of serum-CEA level is well-known in most of patients of lung cancer. In our depart-
ment, serum-CEA was studied in 7 cases of thymoma. Three of 7 were non-invasive, 
their CEA values were all below 2.5 ng/mg. In the 4 invasive thymomas, preoperative 
CEA values were 1.0, 2.6, 2.9 and 7.8 ng/mg. These data suggested that elevation of 
CEA may occur in thymoma. Although we are unable to define the elevation of CEA as 
to whether it is from thymoma or lung cancer in the present case, we believethat serum 
CEA may be an indicator of recurrence or progression of thymoma. 
     During follow-up of a surgical patient with thymoma, the possibility of a non-
thymic malignancy must be kept in mind. It is reported that the highest incidence of non-
thymic malignancy associated with thymoma is 10 to 15 years after the diagnosis of a 
thymoma16). In the long-term follow-up of resected thymoma, in addition to recurrent 
thymoma, screening for non-thymic malignancy is required.
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